Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-02-24
1993-03-23
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
051964368
ABSTRACT:
The subject invention involves antitussive pharmaceutical compositions for the peroral administration of dextromethorphan, the composition being at a pH of from about 8 to about 11.
REFERENCES:
patent: 4427681 (1984-01-01), Munshi
patent: 4454140 (1984-06-01), Goldberg et al.
patent: 4892877 (1990-01-01), Sorrentino
Chem. Abstr-100 109144J (1984).
Chem. Abst.-106-72813k (1987).
Merck Index, 10th Edition (1983), M. Windholz ed., No. 8009, p. 1170.
Physician's Desk Reference for Nonprescription Drugs, 11th Edition (1990), E. R. Barnhardt, pub., p. 306.
Physician's Desk Reference, 44th Edition (1990), E. R. Barnhardt, publ. p. 309.
Beckett, A. H. and E. G. Triggs, "Buccal Absorption of Basic Drugs and Its Application as an In Vivo Model of Passive Drug Transfer Through Lipid Membranes", Journal of Pharmaceutics and Pharmacology, vol. 19 Supplement (1967), pp. 31S-41S.
Friedman S. J.
Graff, IV M. B.
O'Flaherty T. H.
The Procter & Gamble & Company
Yetter J. J.
LandOfFree
Dextromethorphan antitussive compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dextromethorphan antitussive compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dextromethorphan antitussive compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1351966